suma/fever

FIELD OF THE INVENTION The present invention relates to a specialized method for whole-body hyperthermia, including extracorporeal blood heating and dialysis, as an antiviral protocol. BACKGROUND OF THE INVENTION Hyperthermia as a treatment of tumors has been carefully studied and applied since the

FIELD OF INVENTION The present invention relates to a magnetic nanoparticle for tumor therapy, and particularly to a magnetic nanoparticle including an antibody and an anti-tumor drug, which achieves effective treatment of tumor therapy by synergistic effects between hyperthermia and targeted

FIELD OF THE INVENTION The present invention relates to a specialized method for whole-body hyperthermia, including extracorporeal blood heating and dialysis, as an antiviral protocol. BACKGROUND OF THE INVENTION Hyperthermia as a treatment of tumors has been carefully studied and applied since the

BACKGROUND 1. Field of Invention This invention relates to hyperthermia and immunotherapy for treatment of cancer. BACKGROUND 2. Description of Prior Art The earliest references to treating cancer with hyperthermia can be found in Egyptian papyrus scrolls dated back to 3000 BC describing a breast

FIELD OF THE INVENTION The present invention relates to a specialized method and to disposable units for the circulation of fluids for perfusion-induced hyperthermia, including extracorporeal blood heating and sorbent-based detoxification, as an antiviral and antineoplasm protocol. BACKGROUND OF THE

FIELD OF THE INVENTION The present invention relates to a specialized method for hyperthermia, including extracorporeal blood heating and sorbent-based detoxification, as an antiviral and antineoplasm protocol. BACKGROUND OF THE INVENTION Hyperthemia as a treatment of tumors has been carefully

FIELD OF THE INVENTION The present invention generally relates to a device and a procedure for applying heat to tissue, and more specifically, to the use of this device and procedure for enhancing the effects of a medical treatment that depends upon the perfusion of a reagent into the

BACKGROUND 1. Field of Invention This invention relates to hyperthermia and immunotherapy for treatment of cancer. 2. Description of Prior Art The earliest references to treating cancer with hyperthernia can be found in Egyptian papyrus scrolls dated back to 3000 BC describing a breast cancer

BRIEF SUMMARY OF THE INVENTION The invention relates to 1-[2-(4,5,10,11-tetrahydro-1H-dibenzo[a,d]cyclohepten-5-yl)ethyl]pyrrolidi ne of the formula ##STR2## and its pharmaceutically acceptable acid addition salts, which have valuable histamine-H.sub.1 antagonistic properties and are suitable for

BACKGROUND OF THE INVENTION The present invention is novel compounds which are 3,5-di-tertiary-butyl-4-hydroxyphenyl substituted 1,2,4- and 1,3,4-thiadazoles and oxadiazoles, and 1,2,4-triazoles, and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and

BACKGROUND OF THE INVENTION The present invention is novel compounds which are 3,5-di-tertiary-butyl-4-hydroxyphenyl substituted 1,2,4- and 1,3,4-thiadazoles and oxadiazoles, and 1,2,4-triazoles, and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and

BACKGROUND OF THE INVENTION The present invention is novel compounds which are 3,5-di-tertiary-butyl-4-hydroxyphenyl substituted 1,2,4- and 1,3,4-thiadazoles and oxadiazoes, and 1,2,4-triazoles, and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and

FIELD OF THE INVENTION This invention relates to the anti-viral drugs such as Helioxanthin and its analogs compounds. These compounds may be used alone or in combination with other drugs for the treatment of the following: Hepatitis B virus (HBV), Hepatitis C virus (HCV), Yellow Fever, Dengue Virus,

This invention relates to a compound useful in medicine, to the synthesis of the compound, to pharmaceutical formulations containing the compound or a salt thereof and the preparation of such formulations, and to the use of the compounds in medicine. We have found that the compound of formula (I),

BACKGROUND OF THE INVENTION The present invention is novel compounds which are 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and methods of use therefor. The invention compounds are now